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Choose a side
 
inhibitors at developing frog embryos. Many of the chemicals 
that disrupted LR asymmetry (e.g., caused the normally left-
lying heart to be situated on the right) displayed a common 
attribute: they influenced potassium transport into or out of 
the cell. More specific compounds revealed that inhibiting the 
H
 
 
 
/K
 
 
 
 ATPase transporter upset asymmetric gene expression 
patterns known to dictate the hemisphere in which organs 
form.
The H
 
 
 
/K
 
 
 
 ATPase is the first determinant found upstream 
of the asymmetric gene expression cascade. In frogs, LR 
asymmetry was set as early as the two-cell stage, at which point 
the H
 
 
 
/K
 
 
 
 ATPase mRNA was often already asymmetrically 
localized near the point of cell–cell contact. The H
 
 
 
/K
 
 
 
 
ATPase mRNA was not asymmetric in chick embryos, but 
the pump did establish a voltage difference between cells on 
opposite sides of the primitive streak.
It is still unclear how the pump affects downstream gene 
expression. Transporter activity on one side of the embryo or 
streak could make the cell interior more negatively charged, 
and thus could drive an electrophoresis effect between cells. 
But, to support their electrophoresis model, Mercola must 
determine whether the cells affected by the ATPase are the 
cells linked by the asymmetry-promoting gap junctions. 
Alternatively, the pump may directly regulate some factor 
that leads to asymmetry. 
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Little PIP, little PIP, let me in
 
n one simple hydrolysis step, 
bacteria make the plasma 
membrane squishy enough to 
ease invasion, according to new 
results from two groups.
The groups studied different 
pathogens, but both came to 
similar conclusions. Both bacteria, 
 
Shigella
 
 and 
 
Salmonella
 
, inject 
I
 
several invasion-promoting proteins into 
the host, including a protein with similarity 
to a mammalian inositol phosphatase. 
Mauricio Terebiznik, Sergio Grinstein 
(Hospital for Sick Children, Toronto, 
ON), and colleagues watched how 
phosphoinositides were affected during 
 
Salmonella
 
 infection. They found that one 
PIP
 
2
 
 species, PtdIns(4,5)P
 
2
 
, was depleted 
from the base of membrane ruffles that 
formed where bacteria were pushing to get 
in, thanks to the phosphatase activity of 
the SigD effector protein. Like SigD, the 
 
Shigella
 
 effector IpgD studied by Kirsten 
 
ividing an organism into unequal halves just took a giant 
step backward—in time, that is. Michael Levin, Mark 
Mercola (Harvard Medical School, Boston, MA), and 
colleagues have identified what is so far the earliest-acting 
determinant of left/right (LR) asymmetry. According to their 
findings, this early determinant establishes voltage differences 
that distinguish left from right.
D
H
 /K
  ATPase mRNA (purple) is unevenly localized as early 
as the two-cell stage (middle) in frogs.
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Based on previous evidence that gap junctions are 
required for LR asymmetry, the group devised a simple 
model to explain how asymmetry determinants might be 
driven directionally through gap junctions in a process akin 
to electrophoresis. Though he did not necessarily believe the 
model, Mercola says, “the idea that voltage differences and 
channels or pumps may be important was testable.”
And tested it was. In what Mercola likes to call the Sigma 
catalogue screen, the authors threw hundreds of ion flux 
 
Nieburh (Institut Pasteur, Paris, France), 
Bernard Payrastre (INSERM, Toulouse, 
France), and colleagues also removed PIP
 
2
 
 
from target cells; in this case, the product 
was identified as PtdIns(5)P.
The result in both cases was a softer 
plasma membrane. Expression of either 
phosphatase in mammalian cells caused 
membrane blebbing and relaxed attachment 
between the actin cytoskeleton and the 
membrane. Vesicles were released from 
the membrane into the SigD-expressing 
cells. The loosened membrane sped up 
bacterial invasion—
 
Salmonella
 
 mutants 
PIP2 (green) is eliminated by bacteria (pink) that express SigD (right).
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lacking SigD were slower to gain 
entry.
Although PtdIns(5)P may 
affect membrane-cytoskeleton 
interactions, both groups imagine 
that the loss of PIP
 
2
 
 is at the 
heart of it all. “Actin cross-linkers 
are bound by PIP
 
2
 
,” says 
Grinstein. “Bacteria have taken 
advantage of this. By chewing away PIP
 
2
 
, 
they weaken the interaction.” The 
weakening of the plasma membrane 
environment may assist the fission of 
vesicles from the membrane. It remains 
to be seen whether phosphatase conversion 
of PIP
 
2
 
 into PtdIns(5)P is a general 
mechanism to control membrane properties 
during other processes, such as motility 
or endocytosis.
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Branching out 
requires VEGF
 
ot all isoforms are created equal. New 
results from Christiana Ruhrberg, 
David Shima (Cancer Research UK, 
London, UK), and colleagues reveal that 
the stickiness of vascular endothelial growth 
factor (VEGF) can make all the difference 
between blood vessels growing larger or 
finding new territory.
VEGF initiates the formation and expansion 
of the vascular system. VEGF isoforms differ 
in their ability to bind to the extracellular 
matrix (ECM), but, in vitro, endothelial 
cell proliferation is stimulated by VEGF 
regardless of its ECM-binding ability.
In the new study, Shima’s group examined 
mice engineered to make only single VEGF 
isoforms. These mice reveal that VEGF 
isoforms have opposing effects on growing 
vessel networks. Although all forms stimulated 
cell growth in vivo, mice that expressed only 
soluble VEGF had expanded microvessels 
with fewer branches. In contrast, microvessels 
in mice with only ECM-binding VEGF were 
narrow and branched excessively.
“Our results indicate that growth is 
integrated with tissues, because the tissue 
provides localized cues by depositing VEGF 
in precise spatial patterns,” says Ruhrberg. 
The road map is provided by ECM-bound 
VEGF, which attracted filopodia extending 
from the tip of a new vessel branch. Soluble 
VEGF did not remain where it was secreted, 
but rather traveled further away, thus 
stimulating expansion of existing vessels 
from a distance. The authors hope to raise 
awareness of isoform-specific effects for 
those considering the use of VEGF for 
therapy to increase or block angiogenesis.
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Blood vessels are missing branches in 
mice with no ECM-bound VEGF (right). 
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An amidation a day keeps apoptosis away
 
apidly dividing cells such as tumor cells are susceptible to DNA damage that 
then induces apoptosis. As a result, DNA-damaging chemicals such as cisplatin 
are used as anticancer treatments. How the majority of nontumor cells survive 
chemotherapy has been mysterious. The trivial explanation is that the cells are 
growth-arrested and thus less susceptible to DNA-damaging agents. But a more 
precise explanation is put forth in a new article by Benjamin Deverman, Steven 
Weintraub (Washington University, St. Louis, MO), and colleagues, who have identified 
an antiapoptotic activity necessary to keep damaged but nondividing cells alive.
The proapoptotic activity that allows tumor 
cells to die is an unusual modification of the 
antiapoptotic protein Bcl-x
 
L
 
 caused by DNA-
damaging agents. This modification, deamidation 
of two asparagine residues, inactivated Bcl-x
 
L
 
, 
thereby allowing cell death to proceed. Growth-
arrested cells escaped apoptosis by blocking 
deamidation. To prevent deamidation, cells 
needed Rb, a tumor suppressor protein that inhibits cell cycle progression. Because 
tumor cells lack Rb, and cycling cells down-regulate Rb, they are more sensitive to 
DNA-damaging agents. “Deamidation is like a checkpoint,” says Weintraub. “If you 
undergo DNA damage in the absence of Rb, then cells are susceptible to death.”
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R
Bcl-xL modification by cisplatin 
is blocked by Rb.
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Arrested cells are Mad as Hec
 
he spindle checkpoint works even when on the move, according to new 
results from Silvia Martin-Lluesma, Volker Stucke, and Erich Nigg (Max-
Planck Institute of Biochemistry, Martinsried, Germany). Against all that has 
been sacred in the field, these researchers find that mitosis can be arrested 
when checkpoint proteins leave the kinetochore.
The checkpoint is activated by 
Mad1 and Mad2 proteins, which 
bind to kinetochores that are not 
attached to the spindle micro-
tubules. The prevailing theory 
has been that release of Mad1/
Mad2 inactivates the checkpoint 
and allows mitosis to proceed.
Nigg and colleagues looked for human Mad1-interacting proteins and 
found Hec1, which recruited Mad1 and Mad2 to kinetochores. Given this 
function, the group was surprised to find that reducing Hec1 prevented 
cells from dividing, despite the fact that Mad1/Mad2 were not on the 
kinetochores. “This is different from all that has been shown so far,” says 
Stucke. “The components are depleted [from kinetochores], but you still 
get arrest and an active checkpoint.” Hec1-depleted cells that also lacked 
Mad2 continued through mitosis and ended in mitotic catastrophe. Thus, 
checkpoint components can signal from the cytoplasm.
According to one model of Mad function, the Mad proteins make a brief 
visit to kinetochores to sample the environment, but then propagate their 
inhibitory signal in the cytoplasm. Hec1 may regulate this process, but for 
now the details of Hec1 action remain obscure. 
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T
Cells without Hec1 (right) stall in mitosis 
although Mad is not at kinetochores.
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